Antiviral Dispensing for Influenza Outpatients Younger Than 65 Years With Comorbidities: A Retrospective Cohort Study
Open Forum Infectious Diseases · 01.07.2026 · 13 (7)
DOI: 10.1093/ofid/ofag439 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Open Forum Infectious Diseases, online erschienen am 22.07.2026. Verfasst von Grazia Grace Mirabito und 5 weiteren Autor:innen. Beteiligte Einrichtung: Influenza Division, National Center for Immunization and Respiratory Diseases (NCIRD), Centers for Disease Control and Prevention, Atlanta, Georgia, …. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Centers for Disease Control and Prevention.
Abstract (Originalsprache)
Background
Real-world evidence on antiviral dispensing for influenza outpatients with underlying medical conditions (UMCs) is limited. We characterized dispensing among influenza outpatients aged <65 years with UMCs, comparing commercial and Medicaid coverage.
Methods
We used outpatient encounter claims from the US MarketScan Commercial and Medicaid databases during October–April of the 2018–2019 through 2023–2024 influenza seasons and October–December 2024–2025. Eligible encounters included patients aged <65 years with a clinical influenza diagnosis, ≥1 UMC, and ≥12 months of continuous enrollment before diagnosis. Antiviral treatment was defined as dispensing of oseltamivir, peramivir, zanamivir, or baloxavir within 7 days of the encounter. We described demographic, clinical, and care-seeking characteristics and evaluated overall and same-day dispensing by insurance type.
Results
Among 549 424 encounters, 268 463 (48.9%) were commercially insured (median age 19 years [interquartile range, IQR, 8–44]) and 280 961 (51.1%) were Medicaid insured (median age 10 years [IQR 5–18]). Chronic pulmonary disease was the most common UMC (88.0% and 81.8%). Antivirals were dispensed in 54.2% (commercial) and 53.7% (Medicaid) of encounters, almost exclusively oseltamivir. Same-day dispensing occurred in 91.1% of commercial and 81.4% of Medicaid encounters. Overall dispensing was lowest among patients with emergency department encounters or multiple outpatient visits; same-day dispensing was lowest among those with multiple UMCs, emergency department encounters, or multiple visits. Dispensing increased with age in commercial encounters but declined among adults with Medicaid.
Conclusions
About half of higher-risk influenza outpatients received antivirals. Overall dispensing was similar by insurance type, but Medicaid patients and those with multiple UMCs had greater delays.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Influenza Division, National Center for Immunization and Respiratory Diseases (NCIRD), Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
ORCID-Profile: Grazia Grace Mirabito, Svetlana Masalovich, Katherine Adams
Förderung
- Centers for Disease Control and Prevention
Zitieren
APA
Mirabito, G. G., Masalovich, S., Uyeki, T. M., Reed, C., Garg, S., & Adams, K. (2026). Antiviral Dispensing for Influenza Outpatients Younger Than 65 Years With Comorbidities: A Retrospective Cohort Study. Open Forum Infectious Diseases, 13(7). https://doi.org/10.1093/ofid/ofag439
Vancouver
Mirabito GG, Masalovich S, Uyeki TM, Reed C, Garg S, Adams K. Antiviral Dispensing for Influenza Outpatients Younger Than 65 Years With Comorbidities: A Retrospective Cohort Study. Open Forum Infectious Diseases. 2026;13(7). doi:10.1093/ofid/ofag439
BibTeX
@article{Mirabito2026,
author = {Mirabito, Grazia Grace and Masalovich, Svetlana and Uyeki, Timothy M and Reed, Carrie and Garg, Shikha and Adams, Katherine},
title = {Antiviral Dispensing for Influenza Outpatients Younger Than 65 Years With Comorbidities: A Retrospective Cohort Study},
journal = {Open Forum Infectious Diseases},
year = {2026},
volume = {13},
number = {7},
doi = {10.1093/ofid/ofag439}
}
EUVIMED